Search Results - "Kumar, Shaan"

Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway by Zhang, Junbing, Simpson, Claire M., Berner, Jacqueline, Chong, Harrison B., Fang, Jiafeng, Ordulu, Zehra, Weiss-Sadan, Tommy, Possemato, Anthony P., Harry, Stefan, Takahashi, Mariko, Yang, Tzu-yi, Richter, Marianne, Patel, Himani, Smith, Abby E., Carlin, Alexander D., Hubertus de Groot, Adriaan F., Wolf, Konstantin, Shi, Lei, Wei, Ting-Yu, Dürr, Benedikt R., Chen, Nicholas J., Vornbäumen, Tristan, Wichmann, Nina O., Mahamdeh, Mohammed S., Pooladanda, Venkatesh, Matoba, Yusuke, Kumar, Shaan, Kim, Eugene, Bouberhan, Sara, Oliva, Esther, Rueda, Bo R., Soberman, Roy J., Bardeesy, Nabeel, Liau, Brian B., Lawrence, Michael, Stokes, Matt P., Beausoleil, Sean A., Bar-Peled, Liron

“…Multiple anticancer drugs have been proposed to cause cell death, in part, by increasing the steady-state levels of cellular reactive oxygen species (ROS)…”
Get full text

Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma by Matoba, Yusuke, Zarrella, Dominique T., Pooladanda, Venkatesh, Azimi Mohammadabadi, Maryam, Kim, Eugene, Kumar, Shaan, Xu, Mengyao, Qin, Xingping, Ray, Lauren J, Devins, Kyle M., Kumar, Raj, Kononenko, Artem, Eisenhauer, Eric, Veillard, Irva E., Yamagami, Wataru, Hill, Sarah J., Sarosiek, Kristopher A., Yeku, Oladapo O., Spriggs, David R., Rueda, Bo R.

“…Background Uterine serous cancer (USC) comprises around 10% of all uterine cancers. However, USC accounts for approximately 40% of uterine cancer deaths, which…”
Get full text

Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations by Pooladanda, Venkatesh, Kumar, Shaan, Matoba, Yusuke, Mohammadabadi, Maryam Azimi, Zarrella, Dominique T., Winter, Ursula A., Hill, Sarah J., Im, Hyungsoon, Rueda, Bo R.

“…Abstract Ovarian cancer stem cells (CSCs) are thought to serve as seed cells for recurrent drug resistant disease. Extracellular vesicles (EVs) derived from…”
Get full text

Abstract 2438: Loss of galectin 3 reveals its potential roles in the aggressive pathology of uterine serous carcinoma by Matoba, Yusuke, Zarrella, Dominique T., Pooladanda, Venkatesh, Kim, Eugene, Kumar, Shaan, Xu, Mengyao, Qin, Xingping, Kumar, Raj, Kononenko, Artem, Veillard, Irva, Sarosiek, Kristopher, Yeku, Oladapo, Spriggs, David R., Rueda, Bo R.

“…Abstract Objective: Uterine serous cancer (USC) represents about 10% of all uterine cancers, yet it accounts for up to 40% of all uterine cancer deaths. This…”
Get full text